广州银诺医药集团股份有限公司（股票代码：02591）于2025年12月3日发布2025年11月股份变动月报。公告显示，截至2025年11月30日，公司注册股本为人民币456,819,349元，包括420,285,370股在香港联交所上市的H股及36,533,979股非上市股份，面值均为每股人民币1元；本月内上述股数无增减变动。
据了解，本月公司并无新增发行股份、购回或注销股份情况，也未进行任何股份期权或股权激励计划的授出、行使或失效，股本结构及数量维持不变。
根据公告所载信息，本次月报由公司联席公司秘书金今签署，公司确认已遵守香港联交所上市规则及相关法律法规。综上所述，截至2025年11月末，公司股本保持稳定。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.